Our journey

September
2023

Closed pre-seed funding round

We are proud to be supported by three of the world’s leading venture capital
firms: LocalGlobe, Softbank Ventures Asia, and The Creator Fund.

October
2023

Moved Into Northdown House

We moved into our new offices in King’s Cross, built a state-of-the-art
biochemistry lab, and made the space our home.

November
2023

First team hires

We welcomed a group of world-class scientists and engineers to join our
team.

March
2024

Designed our first multiplexed biosensor, The Early A1 v0.1

We are able to test for up to eight different biomarkers on a single chip.

June
2024

Partnered with The Behavioural Insights Team (BIT)

The BIT helped us focus on developing a product that people truly want and
will use long-term.

August
2024

Partnered with the Barts Cancer Institute

We began translating a multi-cancer biomarker onto our technology.

September
2024

Team Expanded to 15

We hired incredibly talented colleagues with expertise in regulation, front-end
engineering, data science, and firmware.

December
2024

The Hardware Works

We completed and successfully tested our first fully functional end-to-end
prototype.